1-4 of 4
Brett VanCauwenbergh
Close
Sort by
Journal Articles

High Throughput Pre-Clinical Models to Determine a Synergistic Molar Ratio of 5-Azacitidine to Venetoclax and Uncover Resistance Mechanisms to 5-Azacitidine and Venetoclax Combination Therapy in Acute Myeloid Leukemia

Mithun Milind Sarangdhar, Eric O'Brien, Brett VanCauwenbergh, Jackson Alexander, Caroline Theile, Mitali Basu, Mayur Sarangdhar, William Seibel, John P Perentesis
Journal: Blood
Blood (2022) 140 (Supplement 1): 10693–10694.
https://doi.org/10.1182/blood-2022-163770
Published: 2022
Journal Articles

Modeling Effective AML Therapies - Comparative Anti-Leukemic Synergy of BCL2 and MCL1 Inhibition Combined and with Chemotherapy

Eric O'Brien, BSc, Brett VanCauwenbergh, BSc, Jackson Alexander, Mitali Basu, MSc, Mark Wunderlich, MS, Mayur Sarangdhar, PhD, Benjamin Mizukawa, John P Perentesis
Journal: Blood
Blood (2019) 134 (Supplement_1): 3370.
https://doi.org/10.1182/blood-2019-131613
Published: 2019
Journal Articles

In Vitro Approach for the Identification of Exceptional Responders in Acute Myeloid Leukemia

Eric O'Brien, BSc, Brett VanCauwenbergh, BSc, Luke Byerly, BSc, Alexander Merk, BSc, Mayur Sarangdhar, PhD, Mark Wunderlich, MS, Mitali Basu, MSc, Benjamin Mizukawa, MD, Erin H. Breese, MD PhD, William Seibel, PhD, John Peter Perentesis, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2212.
https://doi.org/10.1182/blood-2018-99-116650
Published: 2018
Journal Articles

Predicting Drug Response and Novel Therapeutic Candidates Using Signatures of Molecular Alterations in Hematologic Malignancies

Guillaume Labilloy, MS, Eric O'Brien, BSc, Brett VanCauwenbergh, BSc, Luke Byerly, BSc, Mitali Basu, MSc, William Seibel, PhD, Erin H. Breese, MD PhD, John Peter Perentesis, MD, Mayur Sarangdhar, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2219.
https://doi.org/10.1182/blood-2018-99-119933
Published: 2018